Low control beliefs, classical coronary risk factors, and socio-economic differences in heart disease in older

H Bosma1, C H M Van Jaarsveld, J Tuinstra

  • 1Health Care Studies, Medical Sociology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. hans.bosma@zw.unimaas.nl

Insights

Low socioeconomic status groups face higher heart disease risks, primarily due to lower control beliefs, not just classical risk factors. This finding highlights a significant, independent pathway influencing cardiovascular health disparities.

Area of Science:

  • Public Health
  • Epidemiology
  • Psychology

Background:

  • Socioeconomic status (SES) is linked to health disparities.
  • Classical coronary risk factors partially explain these disparities.
  • The role of psychological factors like control beliefs remains under investigation.

Purpose of the Study:

  • To investigate if low control beliefs mediate higher heart disease risk in low SES groups.
  • To compare the impact of control beliefs versus classical risk factors on SES-related heart disease risk.
  • To determine if the effect of control beliefs is independent of classical risk factors.

Main Methods:

  • Population-based prospective cohort study in The Netherlands.
  • Inclusion of 3888 participants aged 57+ without prevalent heart disease in 1993.
  • 5-year follow-up to register incident heart disease (myocardial infarction, congestive heart failure).

Main Results:

  • Low SES individuals had a 45% higher risk of heart disease (RR=1.45).
  • Control beliefs accounted for 30% of SES-related heart disease differences.
  • Classical risk factors accounted for only 4% of these differences.
  • The influence of control beliefs was largely independent of classical risk factors.

Conclusions:

  • Low control beliefs significantly contribute to socioeconomic inequalities in heart disease risk.
  • Psychological factors, specifically control beliefs, play a more substantial role than classical risk factors.
  • Interventions targeting control beliefs may help reduce heart disease disparities in lower SES populations.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...